Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model

International Orthopaedics

Volumn 38, Issue 9, 2014, Pages 1955-1962

  Pauley, Penelope ^a,b   Matthews, Brya G ^a   Wang, Liping ^a   Dyment, Nathaniel A ^a   Matic, Igor ^a   Rowe, David W ^a   Kalajzic, Ivo ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Division of Pediatric Infectious Diseases   (United States)

Author keywords

Cell transplantation; Col2.3GFP; Oim; Osteogenesis imperfecta; Osteoprogenitor

Indexed keywords

COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CULTURE; BONE MARROW STROMA CELL; BONE MATRIX; CELL DIFFERENTIATION; CELL EXPANSION; CELL LABELING; CELL MATURATION; CELL TRANSPLANTATION; CIRCULATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORTICAL BONE; ENGRAFTMENT; FEMUR; GRAFT RECIPIENT; IN VITRO STUDY; LOCAL THERAPY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; PROTEIN STRUCTURE; TRABECULAR BONE; ANIMAL; BONE DEVELOPMENT; C57BL MOUSE; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MUTANT MOUSE STRAIN; OSTEOCLAST; PATHOLOGY; SURGERY;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FEMUR; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOGENESIS IMPERFECTA;

EID: 84922833251     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-013-2249-y     Document Type: Article

References (25)

1. Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377-1385 (Pubitemid 38529880)
2. Chamberlain JR, Schwarze U, Wang PR, Hirata RK, Hankenson KD, Pace JM, Underwood RA, Song KM, Sussman M, Byers PH, Russell DW (2004) Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303:1198-1201 (Pubitemid 38233586)
3. Prockop DJ, Oh JY (2012) Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations. J Cell Biochem 113:1460-1469
4. Boban I, Jacquin C, Prior K, Barisic-Dujmovic T, Maye P, Clark SH, Aguila HL (2006) The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells. Bone 39:1302-1312 (Pubitemid 44827922)
5. Boban I, Barisic-Dujmovic T, Clark SH (2010) Parabiosis model does not show presence of circulating osteoprogenitor cells. Genesis 48:171-182
6. Wang LP, Liu YL, Kalajzic Z, Jiang X, Rowe DW (2005) Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. Blood 106:3650-3657 (Pubitemid 41609207)
7. Vanleene M, Saldanha Z, Cloyd KL, Jell G, Bou-Gharios G, Bassett JHD, Williams GR, Fisk NM, Oyen ML, Stevens MM, Guillot PV, Shefelbine SJ (2011) Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood 117:1053-1060
8. Guillot PV, Abass O, Bassett JH, Shefelbine SJ, Bou-Gharios G, Chan J, Kurata H, Williams GR, Polak J, Fisk NM (2008) Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 111:1717-1725 (Pubitemid 351213464)
9. Panaroni C, Gioia R, Lupi A, Besio R, Goldstein SA, Kreider J, Leikin S, Vera JC, Mertz EL, Perilli E, Baruffaldi F, Villa I, Farina A, Casasco M, Cetta G, Rossi A, Frattini A, Marini JC, Vezzoni P, Forlino A (2009) In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 114:459-468
10. Pereira RF, O'Hara MD, Laptev AV, Halford KW, Pollard MD, Class R, Simon D, Livezey K, Prockop DJ (1998) Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95:1142-1147 (Pubitemid 28124926)
11. Otsuru S, Gordon PL, Shimono K, Jethva R, Marino R, Phillips CL, Hofmann TJ, Veronesi E, Dominici M, Iwamoto M, Horwitz EM (2012) Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood 120:1933-1941
12. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309-313 (Pubitemid 29124367)
13. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK (2001) Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97:1227-1231 (Pubitemid 32183743)
14. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T (2002) Isolated allogeneic bonemarrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932-8937 (Pubitemid 34693661)
15. Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH, Lichtler AC, Rowe D (2002) Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 17:15-25 (Pubitemid 33150992)
16. Saban J, King D (1996) PCR genotyping of oim mutant mice. Biotechniques 21(190):192
17. Roguljic H, Matthews BG, Yang W, Cvija H, Mina M, Kalajzic I (2013) In vivo identification of periodontal progenitor cells. J Dent Res 92:709-715
18. Roberts-Pilgrim AM, Makareeva E, Myles MH, Besch-Williford CL, Brodeur AC, Walker AL, Leikin S, Franklin CL, Phillips CL (2011) Deficient degradation of homotrimeric type I collagen, alpha 1 (I)(3) glomerulopathy in oim mice. Mol Genet Metab 104:373-382
19. Uveges TE, Kozloff KM, Ty JM, Ledgard F, Raggio CL, Gronowicz G, Goldstein SA, Marini JC (2009) Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation. J Bone Miner Res 24:849-859
20. Cabral WA, Marini JC (2004) High proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta. Am J Hum Genet 74:752-760 (Pubitemid 38420105)
21. Le Blanc K, Gotherstrom C, Ringden O, Hassan M, McMahon R, Horwitz E, Anneren G, Axelsson O, Nunn J, Ewald U, Norden-Lindeberg S, Jansson M, Dalton A, Astrom E, Westgren M (2005) Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79:1607-1614 (Pubitemid 40847594)
22. Jones GN, Moschidou D, Lay K, Abdulrazzak H, Vanleene M, Shefelbine SJ, Polak J, de Coppi P, Fisk NM, Guillot PV (2012) Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta. Stem Cells Transl Med 1:70-78
23. Kalajzic Z, Li H, Wang LP, Jiang X, Lamothe K, Adams DJ, Aguila HL, Rowe DW, Kalajzic I (2008) Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone 43:501-510
24. Li F, Wang X, Niyibizi C (2010) Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. Bone 47:546-555
25. Pignolo RJ, Kassem M (2011) Circulating osteogenic cells: implications for injury, repair, and regeneration. J Bone Miner Res 26:1685-1693